Labcorp is pursuing numerous strategic initiatives to expand its operations and improve financial performance. The company has recently announced a number of acquisitions including the purchase of select assets from Invitae and BioReference Health's Diagnostics Business. It also plans to buy Baystate Health's outreach lab business. In terms of partnerships, Labcorp announced collaborations with both Philips and Unilabs to advance in digital pathology and companion diagnostics respectively. Labcorp also collaborated with Hawthorne Effect to bring clinical trials directly to patients and investigators in local communities. Additionally, Labcorp has closed several transactions involving stake acquisitions and sales. Labcorp's Q1 2024 results managed to surpass revenue forecasts, although the company reported an EPS lag. Furthermore, Labcorp has declared multiple quarterly dividends and continues to yield returns to its shareholders. Despite these developments, the company's stock had a mixed performance and even underperformed the market on some occasions.
Laboratory Corporation of America Holdings LH News Analytics from Mon, 03 Jul 2023 07:00:00 GMT to Sun, 26 May 2024 13:00:42 GMT -
Rating 4
- Innovation -3
- Information 8
- Rumor -2
